Dry eye disease is a multifactorial condition with significant implications for ocular surface health and patient quality of life. Autologous serum eye drops (ASED) have emerged as an effective biologic treatment, offering essential growth factors, anti-inflammatory mediators, and tear film stabilizers for dry eye patients from moderate to severe. This lecture explores the pathophysiology of dry eye subtypes that benefit from ASEDs, the biochemical composition of serum-based therapy, and the clinical protocols for prescribing serum tears. Attendees will gain a deeper understanding of ASED's role in personalized ocular surface management and learn how to integrate this treatment option into clinical practice.

Almost 1300 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• Wow, I learned a lot today. I have been treating a lot of dry eyes patients via the traditional eye drops, this would be really beneficial for some patients.

• Great serum years pearls. Thanks again Woo U.

• Speaker was strong and knew her material.

• Thank you for making all this information more understandable for me.

• Excellent education in blood serums.

Speaker: Dr. Cecelia Koetting

Moderator: Dr. Elise Kramer

COPE ID: 98949-PH

Category: Pharmacology

This event is COPE approved for 1 hour of CE credit.

Thank you to Vital Tears for exhibiting at the series.